Full course description
Description
This training provides an overview of the Cocaine Use Reduction with Buprenorphine (CURB: CTN-0048) study, focusing on the combination of buprenorphine and naltrexone as a treatment for cocaine dependence. It explores the mechanisms of action, study design, and inclusion criteria for this innovative approach to addressing co-occurring substance use disorders.
Target Audience
Addiction specialists, researchers, healthcare providers, and policymakers interested in advancements in treatment for cocaine and opioid dependence.
Learning Outcomes
After completing this training, you will be able to:
- Understand the rationale and objectives of the CURB study in treating cocaine dependence.
- Explain the mechanisms of action of buprenorphine and naltrexone in combination therapy.
- Identify the key design elements and procedures of the CURB study.
- Recognize the potential implications of this research for clinical practice and addiction treatment policies.